[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM trial [N-acetylcysteine in acute myocardial infarction]) Pasupathy S, Tavella R, Grover S, et al
The defining research property of AOD-9604 is its IGF-1 independence
Stimulants cause tolerance development, meaning increasing doses are needed for the same effect
Future studies should prospectively assess emotional eating, binge-eating symptoms, psychiatric comorbidity, reward sensitivity, learned dietary patterns, and baseline food preferences alongside taste perception, satiety, nausea, liking, wanting, and weight outcomes